Innovative Facility Design
Our state-of-the-art manufacturing facility is designed to optimize personnel and product flow while ensuring stringent regulatory compliance. Each manufacturing suite is appropriately pressurized to mitigate cross-contamination risks. The manufacturing facility is equipped to support both small and large-scale manufacturing of biologics with the following features:
- Single-use platform: Enables flexible and efficient multi-product operations.
- Scalable bioreactor capacity: Multiple single-use bioreactors with capacity ranging from 50L, 200L, 500L up to 3X2000L; future expansion up to 3X5000L
- Product handling: Accommodates titers from less than 1 g/L to 12 g/L.
High-Performance Biologics Development
The facility specializes in biologics development and manufacturing using high-performance cell culture platforms to ensure high-quality and consistent production of drug substances. Our advanced technologies include:
- In-House MCB & WCB manufacturing: Accelerates clinical production.
- Production adaptability: Diverse process platforms including batch, fed-batch, continuous, and intensified processes.
- BPG columns and chromatography skids: Featuring bioprocessing columns ranging from 60 cm to 1 meter and chromatography skids with flow rates of 600 LPH and 2000 LPH.
- High-throughput protein processing: 3 x 2KL bioreactor setup handles up to 24 kg of protein per batch, processing 6 batches monthly (60 annually).
- Productivity enhancement: Increases productivity 2-4 times with intensified processes, in-line buffer dilution, and rapid testing.